Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial CTSUBRES1007-M

Title

Phase III randomized trial of standard adjuvant endocrine therapy +/- chemo in patients with 1-3 positive nodes, hormone receptor positive and Her2 negative breast cancer with recurrence score (RS) of 25 or less

Principal Investigator(s)

John Murray

Details

  • Protocol No. CTSUBRES1007-M
  • Open Date: 05/25/2011
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective:
  • Disease Sites: Breast
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Advantage Clinical ResearchMeharry Medical College
  • Secondary Protocol No: S1007

Description

None Provided.

Eligibility

Not provided. Please call for more information.